OGA inhibitors (Summit)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOGA inhibitors (Summit)
Drug Alias NameO-GlcNAcase -targeting agents (Summit)OGA Inhibitors (Summit)SEG-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSummit Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSummit Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A